Vericiguat for improving heart function in heart failure
Treatments studied
Part of Hormones & metabolism clinical trials.
This study tests a medicine called vericiguat (a pill) to see if it can improve the heart's shape and function in people with heart failure and a weakened pump. You would keep taking your usual heart medications plus the study drug.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older
- You must have a type of heart failure where the heart pumps less strongly than normal, with a pumping strength below 50%
- Your heart failure must have been stable for the past 6 months, meaning no hospital stays or extra water pills for worsening symptoms
- You must have been on the same heart failure medications for at least 3 months
- You must not have low blood pressure, severe kidney or liver disease, or be on certain heart medications (like long-acting nitrates or ED drugs)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether adding a new medicine called vericiguat to standard heart failure treatments helps patients with heart failure feel better and avoid hospital stays. Vericiguat is a pill that may improve heart function and reduce symptoms like shortness of breath and fatigue.
This study checks how safe the medicine vericiguat is for Japanese people with chronic heart failure when used in everyday care. It compares patients who receive vericiguat with patients who continue standard treatments without vericiguat.
This trial tests an investigational medicine called CRD-4730 (taken as a pill) to see if it can improve heart function and symptoms in people with heart failure and a reduced pumping ability. It may help you feel better and slow the progression of your condition.
This study tests whether the drug vericiguat helps people with heart failure after a heart attack. The trial looks at people whose heart pumping is weak and who have symptoms despite standard treatment.
This trial tests how a medication called vericiguat works in people with both chronic kidney disease and heart failure. It aims to see if the drug helps manage these conditions together.
This study tests a drug called vericiguat, which may help people with heart failure and a leaky tricuspid valve. It aims to improve heart function and reduce symptoms.
Hear when a new Chronic Heart Failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.